APLIF
APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF)
$02
About APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF)
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.01
Market cap
2.4M
Dividend yield
0.00%
Volume
--
Avg. volume
37,594
P/E ratio
-.82
APPILI THERAPEUTICS INC by Appili Therapeutics Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.01
Market cap
2.4M
Dividend yield
0.00%
Volume
--
Avg. volume
37,594
P/E ratio
-.82